Fast LiH destruction in reaction with H: quantum calculations and astrophysical consequences (2009)
Bovino, S., Wernli, M., Gianturco, F. A.
We present a quantum-mechanical study of the exothermic 7LiH reaction with H. Accurate reactive probabilities and rate coefficients are obtained by solving the Schrodinger equation for the motion of...
Improved low-temperature rate constants for rotational excitation of CO by H_2 (2006)
Wernli, M., Valiron, P., Faure, A., Wiesenfeld, L., Jankowski, P., Szalewicz, K.
Cross sections for the rotational (de)excitation of CO by ground state para- and ortho-H_2 are obtained using quantum scattering calculations for collision energies between 1 and 520 cm^{-1}. A new...
A full nine-dimensional potential-energy surface for hydrogen molecule-water collisions (2005)
Faure, A., Valiron, P., Wernli, M., Wiesenfeld, L., Rist, C., Noga, J., ...
The hydrogen and water molecules are ubiquitous in the Universe. Their mutual collisions drive water masers and other line emission in various astronomical environments, notably molecular clouds and...
Borner, M. M., Bernhard, J., Dietrich, D., Popescu, R., Wernli, M., Saletti, P., ...
Background: To determine the efficacy, impact on quality-of-life (QoL) and tolerability of two different irinotecan administration schedules in combination with capecitabine as first-line treatment...
Ghielmini, M., Rufibach, K., Salles, G., Leoncini-Franscini, L., Léger-Falandry, C., Cogliatti, S., ...
Background: Predictive factors of rituximab efficacy and its effect on the immune system are still not defined. Patients and methods: Three hundred and six patients with follicular or mantle cell...
Ghielmini, M., Rufibach, K., Salles, G., Leoncini-Franscini, L., Léger-Falandry, C., Cogliatti, S., ...
Background: Predictive factors of rituximab efficacy and its effect on the immune system are still not defined. Patients and methods: Three hundred and six patients with follicular or mantle cell...
Von Rohr, A., Schmitz, S.-F. H., Tichelli, A., Hess, U., Piguet, D., Wernli, M., ...
Background: To assess the activity and toxicity of 2-chlorodeoxyadenosine (cladribine, CDA) given by subcutaneous bolus injections to patients with hairy cell leukemia (HCL). Patients and methods:...
The effect of Rituximab on patients with follicular and mantle-cell lymphoma (2000)
Ghielmini, M., Schmitz, S.-F. Hsu, Bürki, K., Pichert, G., Betticher, D. C., Stupp, R., ...
Background: Clinical activity of the anti CD-20 monoclonal antibody Rituximab has been reported in patients with follicular lymphoma (FL) and mantle-cell lymphoma (MCL). Patients and methods: 120...
Betticher, D. C., Ratschiller, D., Schmitz, S.-F. Hsu, Von Rohr, A., Hess, U., Zulian, G., ...
Purpose To study the efficacy and the safety of cladribine (2-chlorodeoxyadenosine, 2-CDA) administered as 24-hour infusions or as subcutaneous bolus injections at two different doses to patients...
Burgisser, P, Simon, F, Wernli, M, Wust, T, Beya, M F, Frei, P C
A new enzyme immunoassay (EIA), the Cobas Core Anti-HIV-1/HIV-2 EIA DAGS (also referred to as Roche DAGS), for the detection of antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2 was...
Buechner, S A, Wernli, M, Harr, T, Hahn, S, Itin, P, Erb, P
Basal cell carcinoma (BCC) is the most common skin cancer in humans, and although metastasis rarely occurs, the tumor cells are nevertheless able to invade and destroy the surrounding tissue....
Burgisser, P, Simon, F, Wernli, M, Wust, T, Beya, M F, Frei, P C
A new enzyme immunoassay (EIA), the Cobas Core Anti-HIV-1/HIV-2 EIA DAGS (also referred to as Roche DAGS), for the detection of antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2 was...
Buechner, S A, Wernli, M, Harr, T, Hahn, S, Itin, P, Erb, P
Basal cell carcinoma (BCC) is the most common skin cancer in humans, and although metastasis rarely occurs, the tumor cells are nevertheless able to invade and destroy the surrounding tissue....
Leyvraz, S, Herrmann, R, Guillou, L, Honegger, H P, Christinat, A, Fey, M F, ...
Having determined in a phase I study the maximum tolerated dose of high-dose ifosfamide combined with high-dose doxorubicin, we now report the long-term results of a phase II trial in advanced...
Betticher, D C, Hsu Schmitz, S-F, Tötsch, M, Hansen, E, Joss, C, Von Briel, C, ...
The aim was to investigate the efficacy of neoadjuvant docetaxel–cisplatin and identify prognostic factors for outcome in locally advanced stage IIIA (pN2 by mediastinoscopy) non-small-cell lung...